| Literature DB >> 34943726 |
Iouraouine El Mehdi1,2,3, Soraia I Falcão2, Mustapha Harandou1, Saïd Boujraf1, Ricardo C Calhelha2, Isabel C F R Ferreira2, Ofélia Anjos4,5,6, Maria G Campos3,7, Miguel Vilas-Boas2.
Abstract
The venom from Apis mellifera intermissa, the main honey bee prevailing in Morocco, has been scarcely studied, despite its known potential for pharmacological applications. In the present work, we investigated the composition, the anti-inflammatory activity, and the venom's cytotoxic properties from fifteen honey bee venom (HBV) samples collected in three regions: northeast, central, and southern Morocco. The chemical assessment of honey bee venom was performed using LC-DAD/ESI/MSn, NIR spectroscopy and AAS spectroscopy. The antiproliferative effect was evaluated using human tumor cell lines, including breast adenocarcinoma, non-small cell lung carcinoma, cervical carcinoma, hepatocellular carcinoma, and malignant melanoma. Likewise, we assessed the anti-inflammatory activity using the murine macrophage cell line. The study provides information on the honey bee venom subspecies' main components, such as melittin, apamin, and phospholipase A2, with compositional variation depending on the region of collection. Contents of toxic elements such as cadmium, chromium, and plumb were detected at a concentration below 5 ppm, which can be regarded as safe for pharmaceutical use. The data presented contribute to the first study in HBV from Apis mellifera intermissa and highlight the remarkable antiproliferative and anti-inflammatory effects of HBV, suggesting it to be a candidate natural medicine to explore.Entities:
Keywords: Apis mellifera intermissa; NIR; anti-inflammatory activity; bee venom; chemical composition; cytotoxic activity
Year: 2021 PMID: 34943726 PMCID: PMC8698958 DOI: 10.3390/antibiotics10121514
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1(a) Apis mellifera intermissa; (b) Map of Morocco with the site of collection: northeast, center and southern samples.
Figure 2(a) Representative chromatographic profile at 220 nm of A. mellifera intermissa venom (1-apamin; 2-phospholipase A2; IS-internal standard: cytochrome c at 25 µg/mL; 3-melittin); (b) Full scan mass spectrum of apamin (tr = 4.78 min; MW = 2032 Da); (c) Full scan mass spectrum of melittin (tr = 9.80 min; MW = 2846 Da).
Chemical characterization of A. mellifera intermissa venom from northeast, central, and southern Morocco by LC-DAD-ESI/MSn.
| Sample | Apamin (µg/mL) | PLA2 * (µg/mL) | Melittin (µg/mL) |
|---|---|---|---|
| NE1 | 2.08 | 9.13 | 67.16 |
| NE2 | 1.93 | 6.66 | 73.43 |
| NE3 | 2.29 | 6.57 | 78.14 |
| NE4 | 1.99 | 7.4 | 73.85 |
| NE5 | 1.96 | 8.54 | 65.97 |
| Average ± SD | 2.1 ± 0.1 | 8 ± 1 | 72 ± 5 |
| C1 | 1.86 | 4.21 | 71.78 |
| C2 | 2.05 | 5.05 | 73.66 |
| C3 | 1.96 | 7.14 | 71.98 |
| C4 | 2.10 | 8.03 | 75.10 |
| C5 | 1.99 | 6.42 | 70.15 |
| Average ± SD | 2.0 ± 0.1 | 6 ± 1 | 73 ± 2 |
| S1 | 1.53 | 4.52 | 66.78 |
| S2 | 1.69 | 4.18 | 71.29 |
| S3 | 2.55 | 7.81 | 87.70 |
| S4 | 1.79 | 1.79 | 70.29 |
| S5 | 1.45 | 4.45 | 62.34 |
| Average ± SD | 1.8 ± 0.4 | 5 ± 2 | 72 ± 9 |
| [ | 1.5 | 8 | 65 |
| [ | 4.1 | 15 | 58 |
| [ | 2.6 | 13 | 54 |
| [ | 3.5 | 13 | 65 |
NE–northeast; C–center; S–Southern Morocco. SD–Standard deviation. * Significant differences between regions for p ≤ 0.05.
Metal content of A. mellifera intermissa venom from the three regions of Morocco.
| Samples | K * | Na * | Ca * | Mg * | Zn * | Cu | Cd | Cr | Mn | Ni | Pb * |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NE1 | 2.97 | 1.30 | 3.25 | 0.52 | 1.23 | 5.37 | - | 5.20 | 2.02 | 26.98 | 6.13 |
| NE2 | 3.01 | 1.34 | 1.78 | 0.44 | 1.39 | 24.72 | - | 9.46 | 4.46 | 4.32 | 5.15 |
| NE3 | 2.64 | 1.53 | 1.80 | 0.33 | 1.05 | 4.36 | - | 7.61 | 1.61 | 1.36 | 9.85 |
| NE4 | 2.16 | 1.00 | 0.95 | 0.32 | 1.04 | - | 2.26 | 3.86 | 1.10 | - | 8.08 |
| NE5 | 3.57 | 1.55 | 1.76 | 0.57 | 1.03 | 4.13 | - | 8.63 | 2.79 | 0.49 | 6.77 |
| Average ± SD | 2.9 ± 0.5 | 1.3 ± 0.2 | 1.9 ± 0.7 | 0.4 ± 0.1 | 1.2 ± 0.2 | 8 ± 9 | - | 7 ± 2 | 2.4 ± 1.2 | 8 ± 11 | 7.2 ± 1.6 |
| C1 | 1.62 | 1.93 | 4.55 | 0.42 | 1.03 | 9.45 | - | 4.59 | 2.47 | 2.83 | 3.81 |
| C2 | 1.73 | 1.01 | 2.16 | 0.27 | 1.12 | - | - | 3.41 | 1.59 | 0.64 | 3.56 |
| C3 | 3.02 | 1.84 | 3.22 | 0.55 | 1.42 | 20.91 | - | 6.71 | 3.10 | 0.62 | 3.99 |
| C4 | 3.03 | 1.43 | 2.32 | 0.56 | 1.27 | 6.83 | - | 4.99 | 2.07 | 4.49 | 4.84 |
| C5 | 2.50 | 0.98 | 2.59 | 0.38 | 1.53 | 7.30 | - | 8.29 | 3.76 | 1.78 | 5.16 |
| Average ± SD | 2.4 ± 0.6 | 1.4 ± 0.4 | 3.0 ± 0.9 | 0.4 ± 0.1 | 1.3 ± 0.2 | 9 ± 7 | - | 6 ± 2 | 2.6 ± 0.8 | 2.1 ± 1.5 | 4.3 ± 0.6 |
| S1 | 1.55 | 0.79 | 0.96 | 0.28 | 0.93 | - | - | 2.40 | 0.78 | - | 7.60 |
| S2 | 1.68 | 0.81 | 0.97 | 0.27 | 1.03 | 3.95 | - | 2.45 | 1.19 | - | 3.63 |
| S3 | 1.95 | 0.81 | 0.83 | 0.31 | 0.95 | 4.10 | 1.32 | 13.21 | 0.89 | - | 3.24 |
| S4 | 1.72 | 0.92 | 1.41 | 0.25 | 1.07 | - | - | 5.19 | 1.29 | - | 4.32 |
| S5 | 1.56 | 0.79 | 0.95 | 0.25 | 1.07 | 3.95 | - | 5.55 | 2.19 | - | 4.20 |
| Average ± SD | 1.7 ± 0.2 | 0.83 ± 0.05 | 1.0 ± 0.2 | 0.3 ± 0.0 | 1.1 ± 0.1 | 2.4 ± 2 | - | 6 ± 4 | 1.3 ± 0.5 | - | 4.6 ± 1.6 |
NE–northeast; C–center; S–southern Morocco. SD–Standard deviation. * Significant differences between regions for p ≤ 0.05.
Oral, parenteral and inhalation concentration levels (µgg−1), for elemental impurities in the drug substances and excipients set by the ICH guideline Q3D on elemental [34]. Comparison with HBV from the three regions (in mean values).
| Class | Oral | Parenteral | Inhalation | HBV Concentration | ||
|---|---|---|---|---|---|---|
| Cd | 1 | 0.5 | 0.2 | 0.3 | NE | a |
| C | - | |||||
| S | a | |||||
| Pb | 1 | 0.5 | 0.5 | 0.5 | NE | 7.3 * |
| C | 4.3 * | |||||
| S | 4.6 * | |||||
| Ni | 2A | 20 | 2 | 0.5 | NE | 8.2 |
| C | 2.1 | |||||
| S | - | |||||
| Cu | 3 | 300 | 30 | 3 | NE | 8.6 |
| C | 8.9 | |||||
| S | 2.4 | |||||
| Cr | 3 | 1100 | 110 | 0.3 | NE | 6.5 |
| C | 5.6 | |||||
| S | 5.8 | |||||
Class1: Metals of significant safety concerns; Class 2A: Metals with low safety concerns; Class 3: Metals with minimal concerns. NE–northeast; C–center; S–Southern Morocco. a: Detected only in one sample. * Significant differences between regions for p ≤ 0.05.
Figure 3Normalized NIR spectra for HBV, with the indication of the most relevant bands.
Figure 4PCA score plot of the more relevant spectral region of NIR spectra of A. mellifera intermissa venom from the three regions of Morocco (A1) and excluding sample NE5 (B1). (A2,B2) displayed the second derivative pretreatment.
Cytotoxic and anti-inflammatory activity of A. mellifera intermissa venom from the three regions of Morocco.
| Cytotoxic Activity (GI50, µg/mL) | Anti-Inflammatory Activity | ||||||
|---|---|---|---|---|---|---|---|
| HepG2 | NCI_H460 | HeLa | MM127 * | MCF7 * | PLP2 | RAW264.7 * | |
| NE1 | 4.86 | 9.57 | 4.84 | 3.72 | 4.64 | 13.77 | 5.07 |
| NE2 | 4.32 | 7.35 | 3.88 | 3.64 | 4.2 | 15.33 | 4.89 |
| NE3 | 3.58 | 6.88 | 3.75 | 4.01 | 4.17 | 27.15 | 6.06 |
| NE4 | 2.40 | 3.09 | 2.08 | 2.05 | 2.62 | 4.06 | 4.03 |
| NE5 | 4.56 | 7.77 | 3.81 | 3.80 | 4.55 | 8.96 | 4.86 |
| Average ± SD | 3.9 ± 0.9 | 7 ± 2 | 3.7 ± 0.9 | 3.4 ± 0.7 | 4.0 ± 0.7 | 14 ± 8 | 5.0 ± 0.7 |
| C1 | 4.02 | 8.06 | 4.15 | 4.64 | 6.40 | 15.13 | 7.92 |
| C2 | 4.1 | 8.26 | 4.06 | 4.92 | 6.86 | 14.84 | 7.78 |
| C3 | 1.99 | 4.12 | 2.97 | 3.33 | 3.91 | 13.74 | 6.12 |
| C4 | 3.94 | 7.27 | 4.94 | 4.44 | 5.9 | 11.13 | 6.26 |
| C5 | 3.79 | 8.08 | 5.36 | 4.95 | 5.59 | 14.14 | 6.11 |
| Average ± SD | 3.6 ± 0.8 | 7 ± 2 | 4.3 ± 0.8 | 4.5 ± 0.6 | 5.7 ± 1.0 | 14 ± 1 | 6.8 ± 0.8 |
| S1 | 4.95 | 8.85 | 4.67 | 4.99 | 5.94 | 18.03 | 9.08 |
| S2 | 3.98 | 7.85 | 4.36 | 4.49 | 5.52 | 13.93 | 7.40 |
| S3 | 4.33 | 7.17 | 4.67 | 4.24 | 6.02 | 14.86 | 6.65 |
| S4 | 11.46 | 15.3 | 8.71 | 8.09 | 12.1 | 38.85 | 15.5 |
| S5 | 15.63 | 15.6 | 8.35 | 7.68 | 10.8 | 14.12 | 15.0 |
| Average ± SD | 8.0 ± 4.7 | 11 ± 4 | 6.2 ± 1.9 | 5.9 ± 1.7 | 8.1 ± 2.8 | 20 ± 10 | 10.7 ± 3.8 |
| Dexamethasone | 15.5 | ||||||
NE–northeast; C–center; S–Southern Morocco. SD–Standard deviation. GI50-concentration that inhibited 50% of the net cell growth. IC50-Sample concentration providing 50% of inhibition of NO production. * Significant differences between regions for p ≤ 0.05.
Figure 5Cytotoxicity activity of A. mellifera intermissa venom from the three regions (S, South; C, Center; NE, Northeast Morocco). The results are expressed in GI50 values (µg/mL), corresponding to the concentration causing 50% growth inhibition in the five human tumor lines or porcine liver primary culture PLP2.
Pearson’s correlation between the main HBV component (melittin, PLA2 and apamin) and the cytotoxicity and anti-inflammatory activity GI50/IC50 (µg/mL).
| HepG2 | NCI-H460 | HeLa | MCF-7 | MM127 | PLP2 | RAW264.7 | |
|---|---|---|---|---|---|---|---|
| Apamin | −0.497 | −0.490 | −0.409 | −0.430 | −0.483 | −0.053 | −0.560 * |
| PLA2 | −0.412 | −0.443 | −0.391 | −0.555 * | −0.590 * | −0.382 | −0.652 ** |
| Melittin | −0.311 | −0.302 | −0.284 | −0.214 | −0.205 | 0.154 | −0.161 |
GI50-concentration that inhibited 50% of the net cell growth. IC50-Sample concentration providing 50% of inhibition of NO production. * Significant correlation at the (0.05) level; ** significant correlation at (0.01 level).